BHCM
PGEN icon

Brevan Howard Capital Management’s Precigen PGEN Stock Holding History

Brevan Howard Capital Management’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158K Buy
+27,759
New +$120K ﹤0.01% 1941
2026
Q1 		– Sell
-26,267
Closed -$110K – 2404
2025
Q4 		$110K Sell
26,267
-97,475
-79% -$377K ﹤0.01% 1670
2025
Q3 		$407K Buy
+123,742
New +$349K ﹤0.01% 1394

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brevan Howard Capital Management's PGEN Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Precigen (PGEN) in Q2 2026: 27,759 shares worth $158K. The stake represents ﹤0.01% of the portfolio and ranks #1941 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in PGEN as recently as Q4 2025.

Brevan Howard Capital Management first reported a position in PGEN in Q3 2025 and has held it in 3 quarters since. The position peaked at $407K in Q3 2025. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Brevan Howard Capital Management held 27,759 shares of Precigen worth $158K as of Q2 2026.
  • Precigen was a new Brevan Howard Capital Management position in Q2 2026.
  • Precigen made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1941 holding.
  • Brevan Howard Capital Management first reported a position in Precigen in Q3 2025 and has held it in 3 quarters since.
  • Brevan Howard Capital Management's Precigen position peaked at $407K in Q3 2025.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.